Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Liposome + Cisplatin in Preoperative Breast Cancer
NCT02142010Phase 2Unknown
- Sponsor
- Luye Pharma Group
- Start
- Aug 2014
- Primary completion
- Jun 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal paclitaxel in breast cancer, sponsored by Luye Pharma Group. Status: unknown.
02
Drugs
liposomal paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02142010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142010.